Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trial

Journal of the American College of Cardiology

Volumn 32, Issue 3, 1998, Pages 746-752

  Cohen, Jerald L ^a   Cheirif, Jorge ^b   Segar, Douglas S ^c   Gillam, Linda D ^d   Gottdiener, John S ^e   Hausnerova, Eva ^e   Bruns, Denise E ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARTFORD HOSPITAL   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f Molecular Biosystems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALBUNEX; ECHO CONTRAST MEDIUM; FS 069; MICROSPHERE; OCTAFLUOROPROPANE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOCARDIUM; FLUSHING; HEADACHE; HEART LEFT VENTRICLE; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TASTE DISORDER; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ALBUMINS; CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ENDOCARDIUM; FLUOROCARBONS; HEART VENTRICLES; HUMANS; IMAGE ENHANCEMENT; LUNG DISEASES, OBSTRUCTIVE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0031670557     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00311-8     Document Type: Article

References (25)

1. Christiansen C., Kryvi H., Sontum P.C., Skotland T.L. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. Biotechnol Appl Biochem. 19:1994;307-320.
2. Crouse L.J., Cheirif J., Hanly D.E., et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography results of the phase III Albunex multicenter trial . J Am Coll Cardiol. 22:1993;1494-1500.
3. Feinstein S.B., Cheirif J., Ten Cate F.J., et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent initial multicenter clinical results . J Am Coll Cardiol. 16:1990;316-324.
4. Geny B., Mettauer B., Muan B., et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol. 22:1990;1193-1198.
5. Keller M.W., Glasheen W., Kaul S. Albunex a safe and effective commercially produced agent for myocardial contrast echocardiography . J Am Soc Echocardiogr. 2:1989;48-52.
6. Al-Mansour H.A., Pumper G.M., Foley D.A., Kukuzke J.A., Mulvagh S.L. Is harmonic contrast echocardiography the procedure of choice for optimal endocardial border definition [abstr]? J Am Soc Echocardiogr. 11:1998;527.
7. Meza M., Greener Y., Hunt R., et al. Myocardial contrast echocardiography reliable, safe and efficacious myocardial perfusion assessment after intravenous injection of a new echocardiographic contrast agent . Am Heart J. 132:1996;871-881.
8. Nebergall W.H., Schmidt F.C., Holtzclaw H.F. College Chemistry with Quantitative Analysis. 1976;706 DC Heath, Lexington, MA.
9. Albers V.M. Underwater Acoustic Handbook. 1960;Pennsylvania State University Press, Hershey, PA.
10. Swanson D.P. Enhancement agents for ultrasound fundamentals . Swanson D.P., Chilton H.M., Thrall J.H. Pharmaceuticals in Medical Imaging. 1990;682-687 Macmillan Publishing Co, New York, NY.
11. Mattrey R.F. The potential role of perfluorochemicals (PFC's) in diagnostic imaging. Art Cells Blood Subs Immob Biotech. 22:1994;295-313.
12. Wong R.F., Thompson J.T. Prediction of the kinetics of disappearance of sulfur hexafluoride and perfluoropropane intraocular gas bubbles. Ophthalmology. 95:1988;609-613.
13. Walker R., Wiencek J.G., Aronson S., et al. The influence of intravenous ALBUNEX® injections on pulmonary arterial pressure, gas exchange and left ventricular peak intensity. J Am Soc Echocardiogr. 5:1992;463-470.
14. Wiencek J.G., Feinstein S.B., Walker R., Aronson S. Pitfalls in quantitative contrast echocardiography the steps to quantitation of perfusion . J Am Soc Echocardiogr. 6:1993;395-416.
15. Ota T., Hillman N.D., Craig D., Kisslo J., Smith P.K. Contrast echocardiography influence of ultrasonic machine settings, mixing condition and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro . J Am Soc Echocardiogr. 10:1997;31-40.
16. Gandhok N.K., Block R., Ostoic T., et al. Reduced forward output states affect the left ventricular opacification of intravenously administered ALBUNEX® J Am Soc Echocardiogr. 10:1997;25-30.
17. Zotz R.J., Genth S., Mitrovic V., et al. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure. Eur Heart J. 17:1996;302-307.
18. Tiukinhoy S., Bhoopalam S., Winkelmann J.W., et al. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent ALBUNEX® an analysis of its correlation's with pressure and velocity . Invest Radiology. 31:1996;415-422.
19. Mor-Avi V., Shroff S.G., Robinson K.A., et al. Effects of left ventricular pressure on sonicated albumin microbubbles evaluation using an isolated rabbit heart model . J Am Coll Cardiol. 24:1994;1779-1785.
20. Vuille C., Nidorf M., Morissey R.L., Newell J.B., Weyman A.E., Picard M.H. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents. J Am Soc Echocardiogr. 7:1994;347-354.
21. Mor-Avi V., Shroff S.G., Robinson K.A., Cholley B.P., Ng A.F., Lang R.M. Echocardiographic contrast agents and left ventricular contractility evaluation using an isolated rabbit heart model . J Am Soc Echocardiogr. 9:1996;452-461.
22. Skyba D.M., Camarano G., Goodman N.C., et al. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol. 28:1996;1292-1300.
23. Hundley W.G., Kizilbash A., Afridi I., Franco F., Peshock R.M., Grayburn P.A. Intravenous dodecafluoropentane improves determination of left ventricular function during transthoracic echocardiography. J Am Coll Cardiol. 29:1997;520. (Abstr).
24. Burns P.N. Harmonic imaging with ultrasound contrast agents. Clin Radiol. 51:(Suppl 1):1996;50-55.
25. Wei K., Skyba D.M., Firschke C., et al. Interactions between microbubbles and ultrasound in vitro and in vivo observations . J Am Coll Cardiol. 29:1997;1081-1088.